FDA Posts Guidance on Safety Labeling for Drugs and Biologics
The Food and Drug Administration issued a draft guidance on container and carton labeling for prescription drugs and biological products. The draft guidance focuses on how to design container labels and carton labeling in ways that minimize medication errors. Comments on the draft guidance are due by June 24.
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
(Federal Register 04/24/13)